LSL Pharma Group announced the departure of Sylvain Richer, Chief Financial Officer, for personal reasons and to seek new opportunities, effective August 31, 2023. The Company has begun a process to find a successor. Until
then, François Roberge will assume the interim and Mr. Richer will remain available to ensure a smooth transition.